Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Liviro3 recall

This article was originally published in The Tan Sheet

Executive Summary

Los Angeles-based Ebek says Jan. 19 it is issuing a voluntary nationwide recall of its supplement Liviro3 because the product contains tadalafil (Cialis), which is used to treat erectile dysfunction. Therefore, FDA says the product is an unapproved drug. FDA advised Ebek to recall the product because tadalafil may interact with nitrates found in prescription drugs and may lower blood pressure to dangerous levels. No illnesses have been reported to the company. In July 2006 an FDA survey found seven dietary supplements marketed to treat ED contained illegal drugs due to adulteration with active ingredients used in Rx ED treatments (1"The Tan Sheet," July 17, 2006, p. 4)...

You may also be interested in...



Online Sales Of Unapproved Sex Enhancement Supplements Trouble Canada

Health authorities in Canada nearly every week since April have been issuing warnings about sexual enhancement supplements laced with unapproved ingredients normally found in prescription drugs as consumers access the products through online sales

More spiked ED supplements recalled

Los Angeles-based dietary supplement firms Barodon SF and Cosmos Trading voluntarily recalled products FDA found to contain aminotadalafil, an analogue of tadalafil, the active ingredient in Rx drugs used to treat erectile dysfunction. FDA told "The Tan Sheet" it detected the presence of the substance in the firms' products while testing "products promoted as dietary supplements for uses including enhanced sexual performance." The unapproved drugs marketed as supplements present a "threat to consumers because aminotadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels," FDA says. The agency prompted a recall of unapproved tadalafil-containing products in January (1"The Tan Sheet," Jan. 29, 2007, In Brief). Barodon announced its V.MAX recall on March 15, and Cosmos announced its Rhino Max recall on March 16...

FDA Survey Of ED Supplements Shows Contamination With Viagra, Levitra

A "first-of-its-kind" FDA survey of 17 dietary supplements marketed to treat erectile dysfunction revealed that seven of the products are actually illegal drugs due to adulteration with active ingredients used in Rx ED treatments, the agency states in a July 12 release

Topics

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel